Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 701–800 of 1,004
Koca, S., Kiris, İ., Şahin, Ş., Çınar, N., Karşıdağ, S., Hanağası, H. A., Yıldız, G. B., & Baykal, A. T. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136799 · Cited by 24
Pike, S. C., Welsh, N., Linzey, M., & Gilli, F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1019799 · Cited by 22
“While triggering these signaling pathways may be beneficial during acute infections, persistent activation of the innate immune system contributes to neurodegeneration (Heneka et al., 2014).”
BackgroundHMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression
Huang, X., Wang, B., Yang, J., Lian, Y., Yu, H.-Z., & Wang, Y. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100641 · Cited by 26
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 25
“[6–10] endothelial cells and inflammatory cells recruited from the circulation, and by the blood–brain barrier (BBB) when biochemical or mechanical damage occurs [11,12].”
BackgroundProtein structures in Alzheimer's disease: The basis for rationale therapeutic design
Montoliu‐Gaya, L., & Villegas, S. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.10.005 · Cited by 28
Toll‐like receptor‐mediated immune response inhibits prion propagation
Kang, S., Kim, C., Cortez, L. M., Garza, M. C., Yang, J., Wille, H., Sim, V. L., Westaway, D. A., McKenzie, D. I., & Aiken, J. M. (2016) · Glia · doi:10.1002/glia.22973 · Cited by 24
“Innate immune activation and neuroinflammation develop dur- ing the progression of disease and promote pathology, however, they are not believed to be initiating factors of neurodegenerative diseases (Glass et al., 2010; Heneka et al., 2014).”
BackgroundInfluentialAtypical microglial response to biodiesel exhaust in healthy and hypertensive rats
Mumaw, C. L., Surace, M. J., Levesque, S., Kodavanti, U. P., Kodavanti, P. R. S., Royland, J. E., & Block, M. L. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.10.012 · Cited by 22
“pro-inflammatory response is excessive, unregulated, and fails to resolve (Block et al., 2007; Heneka et al., 2014).”
BackgroundRecent progress in metal–organic frameworks for precaution and diagnosis of Alzheimer’s disease
Liao, Z., Zhang, J., Yu, E., & Cui, Y. (2018) · Polyhedron · doi:10.1016/j.poly.2018.06.013 · Cited by 21
Schölwer, I., Habib, P., Voelz, C., Rolfes, L., Beyer, C., & Slowik, A. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01909-2 · Cited by 22
Zinc utilization by microglia in Alzheimer’s disease
Shippy, D. C., Oliai, S. F., & Ulland, T. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107306 · Cited by 28
“Neuroin fl ammation was initially thought to occur only in the later stages of AD, and glial activation was believed to coincide with, but not signi fi cantly contribute to, AD pathology (69, 70).”
BackgroundDarmanto, A. G., Yen, T., Jan, J., Linh, T. T. D., Taliyan, R., Yang, C. H., & Sheu, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107564 · Cited by 25
Jadhav, V. S., & Khatri, D. K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102872 · Cited by 24
γ‐Secretase in microglia – implications for neurodegeneration and neuroinflammation
Walter, J., Kemmerling, N., Wunderlich, P., & Glebov, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14224 · Cited by 25
Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain
Taetzsch, T., Benusa, S. D., Levesque, S., Mumaw, C. L., & Block, M. L. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1446-z · Cited by 23
Photoreceptors Degenerate Through Pyroptosis After Experimental Retinal Detachment
Li, X., Liu, Y., Sun, M., Gao, M., Li, T., Liang, J., Zhai, Y., Xu, M., She, X., Yang, S., et al. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.8.31 · Cited by 22
Joshi, L., Plastira, I., Bernhart, E., Reicher, H., Koyani, C. N., Madl, T., Madreiter-Sokolowski, C., Koshenov, Z., Graier, W. F., Hallström, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041968 · Cited by 22
“Neurodegenerative disorders that are characterized by an inflammatory response [3] are accompanied by activation of the innate immune cells of the CNS.”
BackgroundMukherjee, S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08518 · Cited by 27
“Several recent studies now indicate that a dysfunctional immune system also underlies pathology of other central nervous system diseases, such as neurodegenerative diseases AD, PD and HD [13, 16, 17, 29, 50, 51].”
BackgroundMacdonald, J. A., Chen, J. L., Masuda‐Suzukake, M., Schweighauser, M., Jaunmuktane, Z., Warner, T. T., Holton, J. L., Grossman, A., Berks, R., Lavenir, I., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01291-7 · Cited by 22
“Neuroinflammation is a common pathological characteristic of major neurodegenerative diseases [64].”
BackgroundWang, Y., Li, J., Wang, M.-Y., Pan, Z.-Y., Li, Z., & Wang, Z.-F. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.122 · Cited by 23
Marchetti, B., Giachino, C., Tirolo, C., & Serapide, M. F. (2022) · Aging Cell · doi:10.1111/acel.13575 · Cited by 24
Nakao, V. W., Mazucanti, C. H., Lima, L. D. S., Mello, P. S. D., Port’s, N. M. D. S., Kinoshita, P. F., Leite, J. A., Kawamoto, E. M., & Scavone, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-21132-4 · Cited by 22
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
The emerging role of IL‐38 in diseases: A comprehensive review
Chen, W., Xi, S., Ke, Y., & Lei, Y. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.991 · Cited by 26
“The neuroinflammation mediated by microglia is suggested to be involved in AD development.(25,26) Microglia expresses receptors such as toll‐like receptors to activate NLRP3 inflammasome to inflammation.”
BackgroundHannon, E. J., Dempster, E. L., Chioza, B. A., Davies, J. P., Blake, G. E. T., Burrage, J., Policicchio, S. S. S., Franklin, A., Walker, E., Bamford, R. A., et al. (2024) · BMC Biology · doi:10.1186/s12915-024-01827-y · Cited by 27
“This finding does not contradict reports that astrocytes and microglia exhibit enhanced activity in Alzheimer’s disease [12, 13, 55].”
ResultChen, W., Liu, M., Li, Z., Luo, Z.-C., & Wu, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114949 · Cited by 24
Olofsson, H. E., & Englund, E. M. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12552 · Cited by 24
MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury
Qin, X., Akter, F., Qin, L., Xie, Q., Liao, X., Liu, R., Wu, X., Cheng, N. H., Shao, L., Xiong, X., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02886-2 · Cited by 22
Peña‐Ortega, F. (2019) · Current Alzheimer Research · doi:10.2174/1567205017666191213162233 · Cited by 21
Increased levels of NLRP3 in children with febrile seizures
Liu, Z., Xian, H., Ye, X., Chen, J., Ma, Y., & Huang, W. (2020) · Brain and Development · doi:10.1016/j.braindev.2019.12.013 · Cited by 23
Inhibition of miR-96-5p in the mouse brain increases glutathione levels by altering NOVA1 expression
Kinoshita, C., Kikuchi-Utsumi, K., Aoyama, K., Suzuki, R., Okamoto, Y., Matsumura, N., Omata, D., Maruyama, K., & Nakaki, T. (2021) · Communications Biology · doi:10.1038/s42003-021-01706-0 · Cited by 26
Type I interferon signalling and interferon‐responsive microglia in health and disease
López‐Atalaya, J. P., & Bhojwani-Cabrera, A. M. (2025) · FEBS Journal · doi:10.1111/febs.70126 · Cited by 26
Jiang, Y., Zhou, Y., Li, Z., & Guo, L. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03590-w · Cited by 29
“While Aβ peptide accumulation can trigger oxidative stress, it can also set off the polarization of microglia and, thus, the release of pro-inflammatory cytokines like interleukins and tumor necrosis factor [233, 234].”
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 21
Cheng, Y., Zeng, X., Mai, Q., Bai, X., Jiang, Y., Li, J., Fan, S., & Ding, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166124 · Cited by 21
Huang, W. Y., Lv, Q.-K., Xiao, Y., Zhong, Z., Hu, B., Yan, S., Yan, Y., Zhang, J., Shi, T., Jiang, L., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.745815 · Cited by 22
“Activation of microglia was found both in autopsy of patients with PD and in MPTP-treated PD mice (Hirsch and Hunot, 2009; Yao et al., 2018).”
BackgroundMechanisms of NLRP3 activation and pathology during neurodegeneration
Jose, S., Groves, N. J., Roper, K. E., & Gordon, R. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106273 · Cited by 23
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 23
Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
Zheng, Z., Zhang, S., Zhang, H., Gao, Z., Wang, X., Liu, X., Cheng, X., Yao, L., & Lu, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7965433 · Cited by 23
“There is a relatively high in fl amma-tory expression in brain tissue, cerebrospinal fl uid, and blood of patients with PD [183].”
Ravenhill, S. M., Evans, A. H., & Crewther, S. G. (2023) · Antioxidants · doi:10.3390/antiox12051117 · Cited by 25
DNA from multiple viral species is associated with Alzheimer's disease risk
Tejeda, M., Farrell, J. J., Zhu, C., Wetzler, L. M., Lunetta, K. L., Bush, W. S., Martin, E. R., Wang, L., Schellenberg, G. D., Pericak‐Vance, M. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13414 · Cited by 20
Xu, J., Gou, S., Huang, X., Zhang, J., Zhou, X., Gong, X., Xiong, J., Chi, H., & Yang, G. (2023) · Current Alzheimer Research · doi:10.2174/0115672050280894231214063023 · Cited by 21
Bachmann, H., Vandemoortele, B., Vermeirssen, V., Carrette, E., Vonck, K. E. J., Boon, P., Raedt, R., & Laureys, G. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.04.012 · Cited by 24
“Ramified microglia are considered homeostatic [8], but under pathological conditions rapidly become activated [9], transforming into an transitional/activated form and ultimately into a highly proinflammatory, amoeboid form [5,8,10 – 13].”
Kanegan, M. J. V., Dunn, D., Kaltenbach, L. S., Shah, B. D., Dong, H., McCoy, D. D., Yang, P., Peng, J., Shen, L., Du, L., et al. (2016) · Scientific Reports · doi:10.1038/srep25626 · Cited by 21
Stress-Induced NLRP3 Inflammasome in Human Diseases
Alcocer‐Gómez, E., Castejón‐Vega, B., & Cordero, M. D. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.02.002 · Cited by 21
Son, H. J., Oh, J. S., Roh, J. H., Seo, S. W., Oh, M., Lee, S. J., Oh, S. J., & Kim, J. S. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4125-x · Cited by 21
Aftabizadeh, M., Tatarek‐Nossol, M., Andreetto, E., Bounkari, O. E., Kipp, M., Beyer, C., Latz, E., Bernhagen, J., & Kapurniotu, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00260 · Cited by 22
Self-citationReversal of β -Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
Wickstead, E. S., Karim, H. A., Manuel, R. E., Biggs, C. S., Getting, S. J., & McArthur, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2139192 · Cited by 22
“More directly, Aβ can act as a damage69 associated molecular pattern [7], stimulating microglial activation through a range of different 70 receptors, including the receptor for advanced glycation end products, toll-like receptors, and 71 CD36 [8].”
BackgroundMicrodevice Platform for In Vitro Nervous System and Its Disease Model
Choi, J., Choi, J., & Cho, H. (2017) · Bioengineering · doi:10.3390/bioengineering4030077 · Cited by 22
“In neurodegenerative diseases, neuroinflammation is one of the main mechanisms for the induction of neuronal loss in the nervous system, through the secretion of pro-inflammatory cytokines from astrocytes and microglia [104,105].”
BackgroundImmune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 23
Hoecke, L. V., Lucci, C., & Vandenbroucke, R. E. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.09.008 · Cited by 28
Sun, Y., Jiang, X., Lü, B., Gao, Q., Chen, Y.-F., Wu, D., Zeng, W., Yang, L., Li, H.-H., & Yu, B. (2020) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-020-3274-5 · Cited by 22
Mechanisms Underlying the Biological Effects of Molecular Hydrogen
Radyuk, S. N. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201211112846 · Cited by 21
Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases
Péladeau, C. L., & Sandhu, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116068 · Cited by 22
A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses
Du, H., Wong, M. Y., Zhang, T., Santos, M. N., Hsu, C., Zhang, J., Yu, H., Luo, W., & Hu, F. (2021) · Life Science Alliance · doi:10.26508/lsa.202000874 · Cited by 21
“They regulate immune homeostasis in the healthy and degenerating CNS. Microglia detect damage-associated molecular patterns (DAMPs) from dying neurons and chronic microglia activation is a hallmark shared in many neurodegenerative diseases (Hanisch and Kettenmann, 2007; Heneka et al., 2014).”
BackgroundAnhydroexfoliamycin, a Streptomyces Secondary Metabolite, Mitigates Microglia-Driven Inflammation
Gegunde, S., Alfonso, A., Alvariño, R., Pérez-Fuentes, N., & Botana, L. M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00033 · Cited by 20
Neshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210480 · Cited by 21
Goyal, A., Gopika, S., Kumar, A., & Garabadu, D. (2022) · Current Drug Targets · doi:10.2174/1389450123666220316091734 · Cited by 21
Neuroinflammation and galectins: a key relationship in neurodegenerative diseases
Hernández, E. R., Olvera, B. A., González, D. C., Marín, O. G., Mercado, D. P., Gil, L. V., Hernández-Zimbrón, L. F., Sánchez‐Salgado, J. L., Limón, I. D., & Zenteno, E. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10064-w · Cited by 23
“Binding of Aβ to CD36 or TLR4 results in overactivation that induces a sustained inflammatory process [57, 59].”
BackgroundLi, S., Sun, Y., Gao, Y., Yu, X., Zhao, C., Song, X., Han, F., & Yu, J. H. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115765 · Cited by 21
Astroglial control of neuroinflammation: TLR3-mediated dsRNA-sensing pathways are in the focus
Salmina, A. B., Komleva, Y. K., Lopatina, O. L., Kuvacheva, N. V., Gorina, Y. V., Panina, Y. A., Uspenskaya, Y. A., Petrova, M. M., Demko, I. V., Zamay, A. S., et al. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0052 · Cited by 19
“Neuroinflammation is caused by brain injury, infection, ischemia, neurodegeneration, and neurodevelopmental alterations and is considered as an important component of pathogenesis in many types of brain pathology (Zindler and Zipp, 2010; Heneka et al., 2014).”
BackgroundCorrigan, F., Arulsamy, A., Teng, J., & Collins‐Praino, L. E. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4589 · Cited by 21
Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets
Gambino, C. M., Sasso, B. L., Bivona, G., Agnello, L., & Ciaccio, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191112093034 · Cited by 22
CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia
van der Ende, E. L., Morenas‐Rodríguez, E., McMillan, C. T., Grossman, M., Irwin, D. J., Sánchez‐Valle, R., Graff, C., Vandenberghe, R. R., Pijnenburg, Y. A. L., Laforce, R. J., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.024 · Cited by 19
NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology
Paesmans, I., Kolen, K. V., Vandermeeren, M., Shih, P., Wuyts, D., Boone, F., Sanchez, S. G., Grauwen, K., Hauwermeiren, F. V., Opdenbosch, N. V., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1459134 · Cited by 20
Immunity in neuromodulation: probing neural and immune pathways in brain disorders
Hours, C. M., Vayssière, P., Gressèns, P., & Laforge, M. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03440-4 · Cited by 21
“Few, if any, neuromodulation protocols take into account the patient’s baseline immune status or immune response, nor do they focus on activating specific immune pathways [6, 7].”
Kostrzewska, P., Kuca, P., Witek, P., Małyszko, J., Madetko‐Alster, N., & Alster, P. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00832-9 · Cited by 23
Podlacha, M., Pierzynowska, K., Gaffke, L., Jerzemowska, G., Piotrowska, E., & Węgrzyn, G. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100482 · Cited by 18
Peng, W., Xie, Y., Liao, C., Bai, Y., Wang, H., & Li, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.966153 · Cited by 17
NLRP3 ‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro
Braatz, C., Komes, M. P., Ravichandran, K. A., de Fragas, M. G., Griep, A., Schwartz, S., McManus, R. M., & Heneka, M. T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15778 · Cited by 21
“A β is cleavaged from amyloid precursor protein (APP) by two proteases, γ - secretase and β - secretase (Heneka et al., 2014).”
Self-citationEchinatin protects from ischemic brain injury by attenuating NLRP3-related neuroinflammation
Sun, L., Chen, D., Zhao, C., Hu, Y., Xu, Y., Xia, S., Yang, H., Bao, X., Zhang, Z., Zhou, C., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105676 · Cited by 19
Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
Beder, N., Belkhelfa, M., & Leklou, H. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241283677 · Cited by 22
“179 – 181 Pyroptosis represents a recently identi fi ed form of programmed cell death intricately linked with in fl ammation.”
Transcriptional programming of human macrophages: on the way to systems immunology
Schultze, J. L. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1286-y · Cited by 20
“Moreover, they play essential roles during sterile inflammation, which is a major hallmark of all major diseases our societies are facing: obesity [3], atherosclerosis [4–8], diabetes [3], neurodegenerative diseases such as Alzheimer’s disease [9, 10], many cancer types [11, 12] and systemic autoimmune diseases [13].”
Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease
Ferguson, S. A., Varma, V., Sloper, D. T., Panos, J., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00512-2 · Cited by 19
Dense module searching for gene networks associated with multiple sclerosis
Manuel, A. M., Dai, Y., Freeman, L. A., Jia, P., & Zhao, Z. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0674-5 · Cited by 19
Giacobbe, J., Pariante, C. M., & Borsini, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936538 · Cited by 23
“In line with previous literature in the field of neuroimmunology (Heneka et al., 2014), our search covered changes related to innate immune activation, encompassing both glial activation and inflammatory reactions.”
ResultDhankhar, J., Agrawal, N., & Shrivastava, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577302 · Cited by 18
Fang, Y., Peng, D., Liang, Y., Lu, L., Li, J., Zhao, L., Ou, S., Li, S., Aschner, M., & Jiang, Y. (2020) · Biological Trace Element Research · doi:10.1007/s12011-020-02471-7 · Cited by 19
Nayak, N., & Mishra, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102066 · Cited by 20
“Genetic abnormality caused due to mutated HTT subsequently causes progressive atrophy of the cortex and striatum [89].”
BackgroundHuang, X., Sang, Z., Liu, H., Yang, J., Wang, K., Qu, Y.-N., & Deng, H. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01669-9 · Cited by 21
“This activation leads to sustained neuroinflammation, which subsequently causes oxidative stress damage and apoptosis in neurons (Heneka et al. 2014).”
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 26
“This consequently entices a further influx of glial cells towards the Aβ site [54–57].”
Son, Y., Park, H.-J., Jeong, Y. J., Choi, H., Kim, N., & Lee, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371379 · Cited by 19
“In many neurodegenerative diseases, microglial activation is a hallmark of lesions, accompanied by an increased number of microglia and dysfunctional phenotypes of microglia (Heneka et al., 2014).”
InfluentialFlavonoids as Promising Multitarget Agents in Alzheimer’s Disease Therapy
Lima, E., Rauter, A. P., & Medeiros, J. (2023) · Applied Sciences · doi:10.3390/app13084651 · Cited by 19
Neuroimmune interactions and their roles in neurodegenerative diseases
Chen, B.-R., Wu, T., Chen, T.-H., & Wang, Y. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.04.002 · Cited by 22
“…disorders, many intracellular or extracellular materials that directly or indirectly derived from neurons, such as A 𝛽 in AD [12 , 13] , 𝛼 -synuclein in PD [12 , 61] and mutant superoxide dismutase 1 (mSOD1) in ALS [12 , 13] , can activate microglia via bind-257 ing to pattern recognition…”
BackgroundInfluentialExploring the effect of gut microbiome on Alzheimer's disease
Pourahmad, R., Saleki, K., Zare, M., Aram, C., Farsani, A. S., Banazadeh, M., & Tafakhori, A. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101776 · Cited by 28
“Other contributors to neuroinflammation comprise vascular endothelium and invading blood cells, especially when the blood-brain barrier (BBB) is disrupted biochemically or mechanically [68,69].”
BackgroundWheeler, H. B., Madrigal, A. A., & Chaim, I. A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317860121 · Cited by 20
Gilli, F., Li, L., & Pachner, A. R. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0369-4 · Cited by 19
“In TMEV-IDD, similarly to situation posited in some neurodegenerative disorders (Heneka et al. 2014), an Binnate-like^ response may exacerbate TMEV-IDD pathology.”
Anti-neuroinflammatory constituents from the fungus Penicillium purpurogenum MHZ 111
Sun, J., Zhu, Z., Song, Y., Ren, Y., Dong, D., Zheng, J., Liu, T., Zhao, Y., Tu, P., & Li, J. (2016) · Natural Product Research · doi:10.1080/14786419.2016.1207075 · Cited by 19
“…in the brain, and it is becoming accepted as a critical factor in the damage of brain function, ranging from acute conditions including delirium and postoperative cognitive dysfunction to chronic diseases such as Alzheimer’s disease and multiple sclerosis (Collins et al. 2012; Heneka et al. 2014).”
BackgroundNeuroinflammation as a therapeutic target in neurodegenerative diseases
Gordon, R., & Woodruff, T. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00003-8 · Cited by 25
Lameth, J., Gervais, A., Colin, C., Lévêque, P., Jay, T. M., Edeline, J., & Mallat, M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9756-3 · Cited by 17
“It is nowwell established that many neuropathological conditions involve an inflammatory reaction in which CNS resident phagocytes, such as microglia, play key roles owing to their capacities to produce a variety of components, among which are cytokines and reactive oxygen species (Heneka et al. 2014; Shemer et al. 20…”
BackgroundNovel insights into the function of the conserved domain of the CAP superfamily of proteins
Olrichs, N. K., & Helms, J. B. (2016) · AIMS Biophysics · doi:10.3934/biophy.2016.2.232 · Cited by 18
“Chronic activation of the immune system is now believed to be a major factor in neurodegenerative diseases and cardiac diseases [55,57].”
BackgroundAutophagy Pathways in CNS Myeloid Cell Immune Functions
Keller, C. W., Münz, C., & Lünemann, J. D. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.09.003 · Cited by 17
Tissue-resident immune cells in the pathogenesis of multiple sclerosis
Tian, J., Jiang, L., Chen, Z.-X., Yuan, Q., Liu, C., He, L., Jiang, F., & Rui, K. (2022) · Inflammation Research · doi:10.1007/s00011-022-01677-w · Cited by 18
“They are derived from yolk sac erythromyeloid progenitors, and exert similar functions of myeloid cells, including phagocytosis, antigen presentation, cytokine production and activation of inflammatory responses [58, 59].”
BackgroundSun, H., Xu, L., Wang, K., Li, Y., Bai, T., Dong, S., Wu, H., & Yao, Z. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00460 · Cited by 18
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Niazi, S., Mariam, Z., & Magoola, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126683 · Cited by 13
“Further research will likely continue to blur the lines between neurodegenerative and autoimmune classifications, potentially leading to novel therapeutic approaches that address both the degenerative and immune aspects of these complex diseases [4].”
BackgroundHosseininasab, S. S. M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K. G., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 21
Rambousek, L., Kletečková, L., Kubesova, A., Jirák, D., Valeš, K., & Fritschy, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.035 · Cited by 14
Chromatin Remodeling in Monocyte and Macrophage Activation
Schultze, J. L. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.09.001 · Cited by 16
Chronic Progressive Neurodegeneration in a Transgenic Mouse Model of Prion Disease
Fainstein, N., Dori, D., Frid, K., Fritz, A. T., Shapiro, I., Gabizon, R., & Ben‐Hur, T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00510 · Cited by 15
“…effects of misfolded proteins (Doyle et al., 2011), oxidative stress and lipid and protein oxidation (Grimm et al., 2011), microglial activation (Heneka et al., 2014), activation of autophagy by intracellular protein aggregates (Yang et al., 2013), and dysfunction of other cellular functions,…”
BackgroundHong-qiang, H., Mang-qiao, S., Fen, X., Liu, S., Cao, H.-J., Hou, W., Yan, W., & Zheng-wu, P. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.017 · Cited by 16
Schipke, C. G., Gunter, O. L., Weinert, C., Scotton, P., Sigle, J.-P., Kallarackal, J., Kabelitz, D., Finzen, A., & Feuerhelm, A. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0003 · Cited by 20
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.